NCT04990973

Brief Summary

The goal of this study is to test the impact of diet on sleep and cardiovascular disease risk factors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

July 26, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 5, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2022

Completed
2 years until next milestone

Results Posted

Study results publicly available

October 17, 2024

Completed
Last Updated

October 17, 2024

Status Verified

October 1, 2024

Enrollment Period

1.3 years

First QC Date

July 26, 2021

Results QC Date

March 25, 2024

Last Update Submit

October 15, 2024

Conditions

Keywords

Mediterranean dietcardiovascular health

Outcome Measures

Primary Outcomes (3)

  • Score on the Pittsburgh Sleep Quality Index (PSQI)

    The 19 questions which compose this survey assess sleep quality, latency, duration, habitual sleep efficiency, sleep disturbances, medication use and daytime dysfunction. Scores range 0 (minimum) to 21 (maximum) with \>5 indicating poor sleep quality so a lower score is a better outcome.

    4 weeks

  • Sleep Fragmentation Index

    Sleep Fragmentation is an index of restlessness during the sleep period expressed as a percentage (0 to 100%). The higher the index, the more sleep is disrupted.

    4 weeks

  • Average Sleep Duration Per Night

    Sleep duration will be actigraphy-derived.

    4 weeks

Secondary Outcomes (4)

  • Change in Urinary 6-sulfatoxymelatonin Level

    Change from baseline to 4 weeks

  • Change in Tryptophan

    Change from baseline to 4 weeks

  • Change in Kynurenine

    Change from baseline to 4 weeks

  • Change in Serotonin

    Change from baseline to 4 weeks

Study Arms (2)

Mediterranean Diet and then AAD

EXPERIMENTAL

Healthy participants that are randomized to the MedDiet followed by a 4-week washout and a crossover to the AAD.

Behavioral: Average American Diet (AAD)Behavioral: Mediterranean Diet

Average American Diet (AAD) and then Mediterranean Diet

EXPERIMENTAL

Healthy participants that are randomized to AAD followed by a 4-week washout and a crossover to the Mediterranean Diet.

Behavioral: Average American Diet (AAD)Behavioral: Mediterranean Diet

Interventions

Participants will follow specified diet requirements. Macronutrient targets for the AAD will be approximately 35-37% of energy from fat (13.5% from saturated fat), 15% from protein, and 48-50% from carbohydrates (10 g fiber/d for an average 2000 kcal/d diet).

Average American Diet (AAD) and then Mediterranean DietMediterranean Diet and then AAD

Participants will follow specified diet requirements. Macronutrient targets for the Mediterranean diet will be approximately 40% of energy from fat (8.5% from saturated fat), 20% of energy from protein, and 40% from carbohydrates (40 g fiber/d for an average 2000 kcal/d diet).

Average American Diet (AAD) and then Mediterranean DietMediterranean Diet and then AAD

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sleep \>6 hours/night
  • Sleep complaints

You may not qualify if:

  • Smoking
  • Allergies to foods
  • Inability to comply with study procedures
  • Gastrointestinal disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

MeSH Terms

Interventions

Diet, Mediterranean

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Results Point of Contact

Title
Dr. Marie-Pierre St-Onge
Organization
Columbia University Irving Medical Center

Study Officials

  • Marie-Pierre St-Onge, PhD

    Columbia University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Statistician and research technicians involved in data and sample analyses will be blind to intervention.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Nutritional Medicine

Study Record Dates

First Submitted

July 26, 2021

First Posted

August 5, 2021

Study Start

July 2, 2021

Primary Completion

October 28, 2022

Study Completion

October 28, 2022

Last Updated

October 17, 2024

Results First Posted

October 17, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

Will be shared upon request and review by investigators.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Upon publication of main study outcomes.
Access Criteria
Determined upon request.

Locations